You’re invited to the 2024 Hepatitis B Foundation Gala on April 5, 2024 in Warrington, PA. Details here.

LiverCancerConnect

Welcome to our Liver Cancer Connect Program

grandpa

 

Find Clinical Trials Near Me!

hepbfoundation livercancer banner 1

Watch our latest webinar!

We introduced new materials we have available tailored for twelve different communities that highlight the link between hepatitis B and liver cancer, and we heard a variety of perspectives about the role this campaign can play in increasing awareness about this connection and encouraging screening for both hepatitis B and liver cancer. Watch the recording here!

New Podcast: Barriers to Liver Cancer Surveillance with Dr. Neehar Parikh

Click here to listen to a new B Heppy Podcast episode! In this episode, Bright and Anousha invited Dr. Neehar Parikh, a hepatologist at the University of Michigan, to discuss the relationship between hepatitis B and liver cancer, disparities in liver cancer rates, and barriers to liver cancer screening in the United States and globally. 

Screenshot 2024 01 17 160711

Check out our latest blog post: Highlighting the Relationship between Hepatitis B and Liver Cancer

Read the blog post here. This post highlights a recent project to develop culturally appropriate educational materials for communities heavily impacted by hepatitis B, about the link between HBV and liver cancer. Materials for twelve different communities are available now - check them out here!

LCD 4

Click here to view and download available materials to spread the word about the connection between HBV and liver cancer! 

Check out this video with a liver cancer survivor on Closing the Care Gap!

This is a clinical trials education video for people who are considering participation in a trial. The video explains and answers common questions about the types of clinical trials, how they are conducted, and factors to think about when deciding whether or not to participate in a trial. The video also features actual patients who share their reasons and decisions about participating in cancer clinical trials.

This panel discussion features someone with lived experience of liver cancer and his wife in conversation with researchers and patient advocates. The discussion highlights what is missing in order to improve the lives of people diagnosed with HCC. Check it out today! 

Liver Cancer Connect is a dedicated program of the Hepatitis B Foundation that was created to provide individuals and families with the information and support they need when facing the challenge of primary liver cancer. Although this is a serious diagnosis, there is good reason to have hope because of the many advances made in the early detection, management and treatment of liver cancer.

GALAD Score Calculator

This is a quick tool that can diagnose HCC based on serum biomarkers in patients with chronic liver disease (CLD) - check it out today!

GALAD Model for Hepatocellular Carcinoma (HCC)

Cancer Support Community Book

This short book outlines the basics of liver cancer diagnosis, management, and supportive measures for those affected. Read the book for free here! 

In the News

3D Contrast-Enhanced Ultrasound in Diagnosing Participants with Liver Cancer Undergoing Stereotactic Ablative Radiotherapy

Adding Immunotherapy to Local Treatment Delays Liver Cancer Progression

Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019

RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma 

Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation of Sesquiterpene Lactone Epimers Trilobolide-6-O-isobutyrate Analogs

Computational-guided approach for identification of PI3K alpha inhibitor in the treatment of hepatocellular carcinoma by virtual screening and water map analysis

Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma

Network-based pharmacology-based research on the effect and mechanism of the Hedyotis diffusa–Scutellaria Barbata pair in the treatment of hepatocellular carcinoma

Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis, and therapeutic decision-making

Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients

Incidence of Etiology-specific Hepatocellular Carcinoma: diverging trends and significant heterogeneity by race and ethnicity

NCCN 2023 Liver Cancer Guidelines for Patients

Gene mutations linked to drug-resistant liver cancer

Complementary and Alternative Medicine

webinar series

View our free webinars to learn about liver cancer treatment, clinical trials, and support services. Webinars are presented in collaboration with Blue Faery: The Adrienne Wilson Liver Cancer Association.

newly diagnosed

Get Connected

square facebook 512 twitter 3 logoTwitter icon horizontal2